A measurement of the ratio of the branching fractions of the B(+) → K(+)μ(+)μ(-) and B(+) → K(+)e(+)e(-) decays is presented using proton-proton collision data, corresponding to an integrated luminosity of 3.0 fb(-1), recorded with the LHCb experiment at center-of-mass energies of 7 and 8 TeV. The value of the ratio of branching fractions for the dilepton invariant mass squared range 1 < q(2) < 6 GeV(2)/c(4) is measured to be 0.745(-0.074)(+0.090)(stat) ± 0.036(syst). This value is the most precise measurement of the ratio of branching fractions to date and is compatible with the standard model prediction within 2.6 standard deviations.
A narrow pentaquark state, P c ð4312Þ þ , decaying to J=ψp, is discovered with a statistical significance of 7.3σ in a data sample of Λ 0 b → J=ψpK − decays, which is an order of magnitude larger than that previously analyzed by the LHCb Collaboration. The P c ð4450Þ þ pentaquark structure formerly reported by LHCb is confirmed and observed to consist of two narrow overlapping peaks, P c ð4440Þ þ and P c ð4457Þ þ , where the statistical significance of this two-peak interpretation is 5.4σ. The proximity of the Σ þ cD 0 and Σ þ cD Ã0 thresholds to the observed narrow peaks suggests that they play an important role in the dynamics of these states.
Observations of exotic structures in the J=ψp channel, which we refer to as charmonium-pentaquark states, in Λ 0 b → J=ψK − p decays are presented. The data sample corresponds to an integrated luminosity of 3 fb −1 acquired with the LHCb detector from 7 and 8 TeV pp collisions. An amplitude analysis of the three-body final state reproduces the two-body mass and angular distributions. To obtain a satisfactory fit of the structures seen in the J=ψp mass spectrum, it is necessary to include two Breit-Wigner amplitudes that each describe a resonant state. The significance of each of these resonances is more than 9 standard deviations. One has a mass of 4380 AE 8 AE 29 MeV and a width of 205 AE 18 AE 86 MeV, while the second is narrower, with a mass of 4449.8 AE 1.7 AE 2.5 MeV and a width of 39 AE 5 AE 19 MeV. The preferred J P assignments are of opposite parity, with one state having spin 3=2 and the other 5=2.
The branching fraction ratio R(D^{*})≡B(B[over ¯]^{0}→D^{*+}τ^{-}ν[over ¯]_{τ})/B(B[over ¯]^{0}→D^{*+}μ^{-}ν[over ¯]_{μ}) is measured using a sample of proton-proton collision data corresponding to 3.0 fb^{-1} of integrated luminosity recorded by the LHCb experiment during 2011 and 2012. The tau lepton is identified in the decay mode τ^{-}→μ^{-}ν[over ¯]_{μ}ν_{τ}. The semitauonic decay is sensitive to contributions from non-standard-model particles that preferentially couple to the third generation of fermions, in particular, Higgs-like charged scalars. A multidimensional fit to kinematic distributions of the candidate B[over ¯]^{0} decays gives R(D^{*})=0.336±0.027(stat)±0.030(syst). This result, which is the first measurement of this quantity at a hadron collider, is 2.1 standard deviations larger than the value expected from lepton universality in the standard model.
A measurement of the ratio of branching fractions of the decays B þ → K þ μ þ μ − and B þ → K þ e þ e − is presented. The proton-proton collision data used correspond to an integrated luminosity of 5.0 fb −1 recorded with the LHCb experiment at center-of-mass energies of 7, 8, and 13 TeV. For the dilepton mass-squared range 1.1 < q 2 < 6.0 GeV 2 =c 4 the ratio of branching fractions is measured to be R K ¼ 0.846 þ0.060 −0.054 þ0.016 −0.014 , where the first uncertainty is statistical and the second systematic. This is the most precise measurement of R K to date and is compatible with the standard model at the level of 2.5 standard deviations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.